A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia. (8th November 2018) - Paul, Shilpa; Jain, Nitin; Ferrajoli, Alessandra; O'Brien, Susan; Burger, Jan; Keating, Michael; Wierda, William